Oct 2026· Presse medicale· pp.
104382
· 0 citations· 48 references
Medicine
TL;DR
A comprehensive overview of the current state and future perspectives of AI in management of cutaneous melanoma is provided, enabling the extraction of morphological and spatial features that are imperceptible to the human eye.
Abstract
Surgical pathology remains the cornerstone for the diagnosis, staging and prognostic stratification of cutaneous melanoma. The emergence of digital pathology and artificial intelligence (AI), notably deep learning, is transforming this field. Convolutional neural networks trained on large repositories of digitised histological slides demonstrate diagnostic capabilities comparable, and in specific tasks superior, to board-certified dermatopathologists. Current applications encompass the automated classification of melanocytic lesions, including the challenging differentiation between benign naevi and early melanoma. Beyond morphological diagnosis, AI algorithms extract virtual biomarkers directly from haematoxylin-eosin-stained slides, predicting underlying molecular alterations, including BRAF mutational status, and offering a transformative approach to prognostic stratification, enabling the extraction of morphological and spatial features that are imperceptible to the human eye. Challenges remain, including dataset bias, inter-laboratory standardisation of whole slide imaging workflows, model interpretability, and medico-legal accountability. The regulatory landscape is rapidly evolving: the European Union Artificial Intelligence Act classifies medical AI as high-risk. The 2024 FDA de novo authorization of DermoSensor, an adjunctive AI-enabled device for assessing suspicious skin lesions, illustrates broader progress in dermatologic AI, although it does not concern surgical pathology. This review provides a comprehensive overview of the current state and future perspectives of AI in management of cutaneous melanoma. These new tools will augment the central role of the pathologist in precision oncology, in refining adjuvant treatment decisions and surveillance strategies in routine clinical practice.
This review examines how computational pathology and convolutional neural networks (CNNs) can improve histopathologic diagnosis and risk stratification of melanoma, evaluate current image-based deep learning (DL) approaches, and outline a path toward explainable, multimodal prognostic tools.
Eudora Lee, R. Karagenova, Y. Semenov· International Journal of Der...· 1 citation
Purpose Differentiating between a choroidal melanoma and metastatic carcinoma to the choroid on cytological specimens presents significant diagnostic challenges due to subtle morphological differences in the sparse cells available in the sample and the increasing scarcity of specialist ocular pathologists. This study d...
Maxine Jackson, H. Kalirai, Rumana N. Hussain et al.· Investigative Ophthalmology...· 0 citations
Advancements in digital pathology and whole-slide imaging have enabled Artificial Intelligence (AI) to emerge as a transformative tool in diagnostic pathology. AI has enabled the automated analysis of histopathological images, improving diagnostic accuracy and reproducibility, as well as workflow efficiency. The aim of...
Alka Yadav, Mithilesh Yadaw· National Journal of Laborato...· 0 citations
AI is revolutionizing histopathology through its ability to enhance diagnostic precision, efficiency, and uniformity in disease identification and classification. The use of machine learning and deep learning algorithms allows for automated analysis of digital tissue images, which is helpful for cancer detection, tumor...
Muhammad Anas· Global Trends in Science and...· 0 citations
Objective: Artificial Intelligence (AI) based digital pathology shows promise in enhancing the histopathological evaluation of dysplastic and premalignant lesions. However, conventional grading of oral epithelial dysplasia, cervical intraepithelial neoplasia, gastric intestinal metaplasia, adenoma, and ductal carcinoma...
Hafsa Aslam, Abdullah Ehsan, Yaqoob Khizar· Journal of Surgery and Advan...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.